Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Observational analysis of nucleocapsid and spike antibody responses post-SARS-CoV-2 infection

Scientists aimed at furthering our understanding of anti-Nucleocapsid and anti-Spike responses over time.

4 Feb 2022

Memory B cells found to potently neutralize SARS-CoV-2 Omicron variant

A team of researchers recently captured memory B cells from a cohort of SARS-CoV-2 convalescent or mRNA-vaccinated individuals to study the evolution of B cell-mediated antibody responses to the N-terminal domain in humans.

4 Feb 2022

Researchers develop influenza virus-like particle-based hybrid vaccine for both influenza and SARS-CoV-2 viruses

In a new study, a team of researchers developed a hybrid vaccine for SARS-CoV-2 and influenza viruses using influenza virus-like particles (VLP).

4 Feb 2022

Investigation of SARS-CoV-2 outbreak in UK office highlights the need for a site-specific COVID-19 prevention strategy

In a new study, researchers comprehensively investigated a public-facing office in England where a SARS-CoV-2 outbreak occurred during August-September 2021 to identify workplace and worker-related risk factors.

4 Feb 2022

Researchers suggest that visible blue light is a safe and variant-agnostic therapy against SARS-CoV-2

In a new study, researchers showed that 425 nm blue light can inactivate all major SARS CoV 2 variants.

4 Feb 2022

Predicting immunity evasion of SARS-CoV-2 Omicron variant of concern

In a new study, a team of researchers assessed the affinity of the SARS-CoV-2 Omicron variant of concern towards major histocompatibility complex (MHC) binding

4 Feb 2022

Study shows SARS-CoV-2 infection can change nasopharyngeal microbiota composition in pregnancy

A recent study from Spain showed that the infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can change the overall structure and diversity of the nasopharyngeal microbiota in pregnant women – which persists even weeks after clinical infection. The paper is currently available on Research Square preprint* server.

3 Feb 2022

Molecular simulations provide insight into SARS-CoV-2 variant RBD interactions with ACE2 and mAbs

Researchers aimed to understand the relationship between the SARS-CoV-2 receptor-binding domain and both human receptors and therapeutic targets.

3 Feb 2022

SARS-CoV-2 human challenge study offers novel insights into viral kinetics

Researchers discuss the results of a human challenge study to provide novel insights into the early dynamics of SARS-CoV-2 infection.

3 Feb 2022

Global efforts to track COVID-19 variants grossly underreported a probable variant of concern in Nigeria

If the United States ignores COVID-19 in Nigeria, we forgo global genomic surveillance at our own peril, reports a new Northwestern Medicine study published in Nature Communications.

3 Feb 2022

Researchers identify a cellular pathway that causes pancreatic beta cells to die in type 1 diabetes

A central feature of type 1 diabetes is loss of the pancreatic beta cells that make insulin. Researchers led by Paolo Fiorina, MD, PhD, of Boston Children's Hospital and Francesca D'Addio, MD, of the University of Milan now identify a harmful cellular pathway that causes these cells to die.

3 Feb 2022

Innate and adaptive immune responses to SARS-CoV-2 in convalescent children and adults

In a new study, researchers explored the systemic immune responses during the acute and convalescent phases of SARS-CoV-2 in children and adults with the same disease severity.

3 Feb 2022

Studying the efficacy of a SARS-CoV-2 vaccine booster dose

In a new study, a team of researchers assessed the efficacy of booster doses of Ad26.COV2.S (Jansen) SARS-CoV-2 vaccine.

3 Feb 2022

Study reveals peripheral blood biomarkers able to predict COVID-19 clinical outcomes in ICU admission

A new study involved the development of an immunological biomarker screen that upon ICU admission can predict the length of ICU stay or death.

3 Feb 2022

Study finds no strong evidence to suggest vaccination improves symptoms of post-acute COVID-19 syndrome

In this study, researchers found no evidence of a strong effect of SARS-CoV-2 vaccination on the symptoms associated with PACS over time.

3 Feb 2022

Neutralizing antibodies against SARS-CoV-2 variants induced by homologous and heterologous COVID-19 booster vaccination

In this study, scientists focused on identifying tentative cut-offs for large-scale evaluations of immune protection against SARS-CoV-2 and its variants.

3 Feb 2022

Red foxes susceptible to SARS-CoV-2 infection

Working towards the aim to determine the SARS-CoV-2 susceptibility of common wildlife species, the researchers in the United States have found that red fox (Vulpes vulpes) can experimentally become infected with SARS-CoV-2 and can shed virus in its oral and nasal secretions.

3 Feb 2022

Antibody News and Research

Further Reading

Observational analysis of nucleocapsid and spike antibody responses post-SARS-CoV-2 infection

Memory B cells found to potently neutralize SARS-CoV-2 Omicron variant

Researchers develop influenza virus-like particle-based hybrid vaccine for both influenza and SARS-CoV-2 viruses

Investigation of SARS-CoV-2 outbreak in UK office highlights the need for a site-specific COVID-19 prevention strategy

Researchers suggest that visible blue light is a safe and variant-agnostic therapy against SARS-CoV-2

Predicting immunity evasion of SARS-CoV-2 Omicron variant of concern

Study shows SARS-CoV-2 infection can change nasopharyngeal microbiota composition in pregnancy

Molecular simulations provide insight into SARS-CoV-2 variant RBD interactions with ACE2 and mAbs

SARS-CoV-2 human challenge study offers novel insights into viral kinetics

Global efforts to track COVID-19 variants grossly underreported a probable variant of concern in Nigeria

Researchers identify a cellular pathway that causes pancreatic beta cells to die in type 1 diabetes

Innate and adaptive immune responses to SARS-CoV-2 in convalescent children and adults

Studying the efficacy of a SARS-CoV-2 vaccine booster dose

Study reveals peripheral blood biomarkers able to predict COVID-19 clinical outcomes in ICU admission

Study finds no strong evidence to suggest vaccination improves symptoms of post-acute COVID-19 syndrome

Neutralizing antibodies against SARS-CoV-2 variants induced by homologous and heterologous COVID-19 booster vaccination

Red foxes susceptible to SARS-CoV-2 infection

Nanoparticle vaccine effective against eight SARS-CoV-2 variants in non-human primates

Antigenic map of SARS-CoV-2 variants reveals amino acid substitutions that govern immune escape and immunodominance

Booster dose of Covaxin vaccine candidate neutralizes Omicron and Delta variants

Industry Focus eBook - Cell biology (5th edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo